A submicron emulsion of HU-211, a synthetic cannabinoid, reduces intraocular pressure in rabbits

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 238, Issue 4, 2000, Pages 334-338

  Naveh, Nava ^a   Weissman, Channa ^a   Muchtar, Shaul ^b   Benita, Shimon ^b   Mechoulam, Raphael ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DEXANABINOL;

ARTICLE; CONTROLLED STUDY; EMULSION; FEMALE; INTRAOCULAR PRESSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0034018676     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004170050361     Document Type: Article

References (34)

1. Bar-Ilan A (1984) Diurnal and seasonal variations in intraocular pressure in the rabbit. Exp Eye Res 39:175-181
2. Beilin M, Bar-Ilan A, Belkin M, Howes JF, Neumann R(1994) Mechanistic studies on the IOP lowering effect of HU-211, a non psychotropic cannabinoid. Invest Ophthalmol Vis Res Sci 35 [Suppl]:674
3. Bidaut-Russell M, Devance WA, Howlett AC (1990) Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. J Neurochem 55:21-26
4. 9-tetrahydrocannabinol and cannabigerol. J Ocul Pharmacol 6:259-269
5. 9 tetrahydro-cannabinol after ophthalmic administration to the rabbit. J Pharm Sci 72:136-138
6. Feigenbaum JJ, Bergmann F, Richmond SA, Mechoulam R, Nadler V, Kloog Y, Sokolovsky M (1989) A non-psychotropic cannabinoid acts as a functional N-methyl-D-aspartate (NMDA) receptor blocker. Proc Natl Acad Sci 86:9584-9587
7. Green K (1982) Marijuana and the eye. J Cutan Ocul Toxicol 1:3-32
8. 2 and tetrahydrocannabinol in the eye. Invest Ophthalmol. Vis Sci 15:102-111
9. Green K, Pederson JE (1973) Effect of tetrahydrocannabinol on aqueous dynamics and ciliary body permeability in the rabbit. Exp Eye Res 15:499-507
10. 9-tetrahydrocannabinol. Invest Ophthalmol Vis Sci 13:422-429
11. 9 -tetrahydrocannabinol in man. Arch Ophthalmol 100:265-267
12. Green K, Symonds CM, Oliver NW, Elijah RD (1982) Intraocular pressure following systemic administration of cannabinoids. Curr Eye Res 2:247-253
13. Green K, Cheeks KE, Watkins L, Bowman KA, McDonald TF, Ocasio H, Deutsch HM, Hodges LC, Zalkow LH (1987) Prostaglandin involvement in the responses of the rabbit eye to water-soluble marijuana-derived material. Curr Eye Res 6:337-344
14. Hepler RS, Frank IR (1971) Marijuana smoking and intraocular pressure. JAMA 217:1392
15. 9 -tetrahydrocannabinol in human eyes. Arch Ophthalmol 101:591-593
16. Levy MY, Benita S (1984) Design and characterization of submicron o/w emulsion of diazepam for parenteral use. Int J Pharm 54:103-112
17. Liu JH, Dacus AC (1987) Central nervous system and peripheral mechanisms in ocular hypotensive effect of cannabinoids. Arch Ophthalmol 105:245-248
18. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564
19. McDonald TF, Cheeks L, Slagle T, Green K (1991) Marijuana-derived material-induced changes in monkey ciliary processes differ from those in rabbit ciliary processes. Curr Eye Res 10:305-312
20. Mechoulam R (1973) Marijuana: Chemistry and pharmacology, metabolism, and clinical effects. Academic Press, New York
21. Mechoulam R, Feigenbaum JJ (1987) Towards cannabinoid drugs. In: Ellis GP, West GB (eds) Progress in medicinal chemistry, vol 24. Elsevier, Amsterdam, pp 159-207
22. Mechoulam R, Lander N, Dikstein S, Carlini EA, Blumenthal M (1975) On the therapeutic possibilities of some cannabinoids. In: Cohen S, Stillman RC (eds) The therapeutic potential of marijuana. Plenum Press, New York, pp 35-45
23. Mechoulam R, Lander N, Breuer A, Zahalka J (1990) Synthesis of the individual, pharmacologically distinct, enantiomers of a tetrahydrocannabinol derivative. Tetrahedron Asymmetry 1:315-319
24. Mechoulam R, Vogel Z, Barg J (1994) CNS cannabinoid receptors: role and therapeutic implications for CNS disorders. CNS Drugs 2:255-260
25. Merrit JC, Crawford WJ, Alexander PC, Auduze AL, Gelbart SS (1980) Effect of marijuana on intraocular pressure and blood pressure in glaucoma. Ophthalmology 87:222-228
26. Mikawa Y, Matsuda S, Kangawa T, Tajika T, Ueda N, Mimura Y( 1997) Ocular activity of topically administered anandamide in the rabbit. Jpn J Ophthalmol 41:217-220
27. Monro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65
28. Muchtar S, Benita S (1994) Emulsions as drug carriers for ophthalmic use. Colloids Surfaces A Phys Eng Aspects 91:181-190
29. Muchtar S, Almog S, Torracca MT, Saettone MF, Benita S (1992) A submicron emulsion as ocular vehicle for delta-8-tetrahydrocannabinol: effect on intraocular pressure in rabbits. Ophthalmic Res 24:142-149
30. Naveh N, Muchtar S, Benita S (1994) Pilocarpine incorporated into a submicron emulsion vehicle causes an unexpectedly prolonged ocular hypotensive effect in rabbits. J Ocul Pharmacol 10:509-520
31. Pate DW, Jarvinen K, Urtti A Mahadevan V, Jarvinen T( 1998) Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits. Life Sci 63:2181-2188
32. Perez-Reyes M, Timmons MC, Davis KH, Wall EM (1973) A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol. Experientia 29:1368-1369
33. Porcella A, Casellas P, Gessa GL, Pani L (1998) Cannabinoid receptor CB1 mRNA is highly expressed in the ciliary body: implications for the antiglaucoma properties of marihuana. Brain Res Mol Brain Res 15:240-245
34. Tiedeman JS, Shields MB, Weber PA, Crow JW, Cocchetto DM, Harris WA, Howes JF (1981) Effect of synthetic cannabinoids on elevated ocular pressure. Ophthalmology 88:270-277